Multi-specialty hospital chain offering tertiary & quaternary care across 5 South & West Indian states
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 74 | 78 | 80 | 80 | 80 | 80 | 80 | 80 |
| Reserves | 550 | 830 | 1.3k | 1.6k | 1.8k | 2.1k | 2.2k | 2.3k |
| Borrowings | 186 | 131 | 18 | 4 | 326 | 708 | 3.2k | 1.5k |
| Other Liabilities | 147 | 175 | 173 | 177 | 204 | 313 | 1.2k | 330 |
| Total Liabilities | 957 | 1.2k | 1.6k | 1.8k | 2.4k | 3.2k | 6.6k | 4.3k |
| AssetsFixed Assets | 559 | 582 | 592 | 612 | 674 | 773 | 4.6k | 1.5k |
| CWIP | 2 | 8 | 13 | 16 | 292 | 530 | 573 | 116 |
| Investments | 178 | 213 | 542 | 826 | 1.1k | 1.2k | 98 | 1.5k |
| Other Assets | 218 | 411 | 422 | 358 | 368 | 660 | 1.3k | 1.1k |
| Total Assets | 957 | 1.2k | 1.6k | 1.8k | 2.4k | 3.2k | 6.6k | 4.3k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 109 | 161 | 291 | 284 | 271 | 262 | 294 | 292 |
| Cash from Investing | -99 | -108 | -317 | -375 | -238 | -569 | -627 | -956 |
| Cash from Financing | -12 | -24 | 25 | 76 | -15 | 289 | 339 | 662 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 63 | 140 | 219 | 215 | 150 | -58 | -12 | -63 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (93.1×) and current (123.2×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At -6.9% growth and a 93× exit, ₹803 only delivers your return if you pay ₹168. The price is currently baking in 24% growth.
EPS grows -6.9%/yr for 5 years, then fades to 6% over 2, exits at 93×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | -6.9% | 6.07 |
| FY28 | -6.9% | 5.65 |
| FY29 | -6.9% | 5.26 |
| FY30 | -6.9% | 4.90 |
| FY31 | -6.9% | 4.56 |
| FY32 | -0.5% ·fade | 4.54 |
| FY33 | 6.0% ·fade | 4.81 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.